PRESS RELEASE published on 05/13/2025 at 07:45, 11 months 25 days ago Eckert & Ziegler Starts with Earnings Growth in Q1 2025 and Confirms Full-Year Forecast Eckert & Ziegler SE reports earnings growth in Q1 2025 with sales of €68.2 million and net income of €9.7 million. Full-year forecast for 2025 confirmed at around €320 million in sales and €78 million in EBIT EBIT Forecast Earnings Growth Sales Forecast Eckert & Ziegler SE Q1 2025
BRIEF published on 04/24/2025 at 14:05, 1 year ago Eckert & Ziegler Signs Manufacturing Agreement with Pentixapharm Clinical Trials Cancer Therapy Manufacturing Agreement Radiopharmaceuticals Y90-PentixaTher
BRIEF published on 04/24/2025 at 14:05, 1 year ago Eckert & Ziegler signe un accord de fabrication avec Pentixapharm Essais Cliniques Accord De Fabrication Produits Radiopharmaceutiques Thérapie Contre Le Cancer Y90-PentixaTher
PRESS RELEASE published on 04/24/2025 at 14:00, 1 year ago Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Pentixapharm Eckert & Ziegler SE signs manufacturing agreement with Pentixapharm for Y90-PentixaTher, a targeted radiolabeled peptide therapeutic for cancer treatment Manufacturing Agreement Eckert & Ziegler SE Radiopharmaceuticals Pentixapharm Y90-PentixaTher
BRIEF published on 04/11/2025 at 10:35, 1 year ago Eckert & Ziegler propose un dividende de 0,50 € pour l'exercice 2024 Eckert & Ziegler Dividende Assemblée Générale Annuelle TecDax Exercice Financier 2024
BRIEF published on 04/11/2025 at 10:35, 1 year ago Eckert & Ziegler Proposes €0.50 Dividend for FY 2024 Annual General Meeting Dividend Eckert & Ziegler Financial Year 2024 TecDax
PRESS RELEASE published on 04/11/2025 at 10:30, 1 year ago Eckert & Ziegler Proposes Dividend of € 0.50 for FY 2024 Eckert & Ziegler SE proposes dividend of €0.50 per share for FY 2024. The Annual General Meeting to be held on June 18, 2025 in Berlin Annual General Meeting Shareholders Dividend Eckert & Ziegler SE FY 2024
BRIEF published on 04/10/2025 at 15:05, 1 year ago Eckert & Ziegler : Le consul américain visite l'usine radiopharmaceutique de Braunschweig Traitement Du Cancer Produits Radiopharmaceutiques Lutécium-177 Visite Du Consul Américain Investissement D'expansion
BRIEF published on 04/10/2025 at 15:05, 1 year ago Eckert & Ziegler: US Consul Visits Braunschweig Radiopharmaceutical Facility Cancer Treatment Radiopharmaceuticals Lutetium-177 US Consul Visit Expansion Investment
PRESS RELEASE published on 04/10/2025 at 15:00, 1 year ago Eckert & Ziegler: US Consul Visits Radiopharmaceutical Production in Braunschweig US Consul General Jason Chue visits Eckert & Ziegler's radiopharmaceutical production site in Braunschweig, witnessing the production of cancer diagnostics and therapy solutions Eckert & Ziegler Cancer Therapy Radiopharmaceuticals Lutetium-177 Transatlantic Cooperation
Published on 05/08/2026 at 00:00, 17 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 47 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 1 hour 2 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 22:05, 2 hours 12 minutes ago MicroVision and Avular Collaborate to Advance Autonomous Sensing and Drone Integration for Next-Generation Infrastructure Applications
Published on 05/07/2026 at 22:05, 2 hours 12 minutes ago Innodata Reports Record First Quarter 2026 Results
Published on 05/07/2026 at 23:23, 53 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 1 hour 2 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 2 hours 11 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 3 hours 34 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 5 hours 31 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 5 hours 2 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 5 hours 2 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 5 hours 11 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 5 hours 11 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 5 hours 17 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
